Inga Deakin is a Partner at Molten Ventures in London, where the firm lists her focus as Lifesciences and Digital Health in the UK. Her firm bio states she has hands-on investment experience in life sciences and digital health working with ventures spun out of leading UK universities, and that she previously worked in the US as Chief of Staff at a commercial-stage genetic molecular diagnostics company and as Entrepreneur in Residence at Duke University. Molten's team spotlight names Deciphex, IMU Biosciences, Hilo, Anima and PolyModels among her investments, and she joined Qureight's board when Molten led its 20 million dollar Series B in 2026. She holds a DPhil and an MSc in Neuroscience from the University of Oxford and a BA from the University of Cambridge.
Education
DPhil in Neuroscience, University of Oxford
MSc in Neuroscience, University of Oxford
BA, University of Cambridge
Previous Experience
Investor in deeptech companies at a venture firm focused on UK university spinouts
Chief of Staff, US commercial-stage genetic molecular diagnostics company